OptimizeRx Corporation (OPRX) Balance Sheet
OPRX balance sheet, 2025
December 31, 2025 · U.S. dollars$176.9M assets = $48.6M liabilities + $128.3M equity
Both columns are drawn to the same scale: what OPRX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
OPRX financial health
Descriptive bands, not a rating. Fiscal 2025.
OPRX balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $11.5M2016 | $176.9M2025 | +35.5%/yr | |
| Total liabilities | $3.7M2016 | $48.6M2025 | +33.3%/yr | |
| Shareholders’ equity | $7.8M2016 | $128.3M2025 | +36.5%/yr | |
| Cash & short-term investments | $7.0M2016 | $23.4M2025 | +14.3%/yr | |
| Total debt | $2.5M2016 | $26.1M2025 | +29.8%/yr | |
| Net cash (debt) | $4.5M2016 | −$2.7M2025 | −$7.3M | |
| Working capital | $6.5M2016 | $43.5M2025 | +$36.9M | |
| Book value per share | $0.792016 | $6.752025 | +26.9%/yr | |
| Current ratio | 2.782016 | 3.042025 | +0.27 | |
| Debt / equity | 0.322016 | 0.202025 | −0.12 | |
| Shares outstanding | 9.9M2016 | 19.0M2025 | +7.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
OPRX assets
OPRX liabilities and equity
OPRX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
OPRX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $23.4M | $13.4M | $13.9M | $74.1M | $84.7M | $10.5M | $18.9M | $8.9M | $5.1M | $7.0M |
| Cash & equivalents | $23.4M | $13.4M | $13.9M | $18.2M | $84.7M | $10.5M | $18.9M | $8.9M | $5.1M | $7.0M |
| Short-term investments | — | — | $0 | $55.9M | $0 | — | — | — | — | — |
| Receivables | $38.5M | $38.2M | $37.3M | $22.2M | $24.8M | $17.9M | $7.4M | $6.5M | $3.4M | $3.1M |
| Inventory | $0 | $0 | $0 | $1.8M | −$5.63T | $0 | $0 | $0 | $1 | $0 |
| Other current assets | $2.8M | $2.4M | $3.2M | $473,652 | $5.63T | $4.5M | $871,043 | $590,744 | $255,427 | $80,820 |
| Total current assets | $64.7M | $54.0M | $54.3M | $98.6M | $115.1M | $32.9M | $27.1M | $16.0M | $8.8M | $10.2M |
| Property, plant & equipment (net) | $510,000 | $516,000 | $722,302 | $372,768 | $472,638 | $594,828 | $735,877 | $149,330 | $167,305 | $173,649 |
| Goodwill & intangible assets | $111.7M | $116.4M | $127.8M | $35.7M | $25.4M | $26.9M | $28.7M | $8.9M | $1.6M | $2.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $28,000 | $296,000 | $568,048 | $5,051 | $12,859 | $12,859 | $80,727 | $5,049 | $0 | $0 |
| Total assets | $176.9M | $171.2M | $183.4M | $134.7M | $141.0M | $60.3M | $56.6M | $25.1M | $9.8M | $11.5M |
| Liabilities | ||||||||||
| Accounts payable | $1.6M | $2.2M | $2.2M | $1.5M | $606,808 | $618,250 | $492,995 | $411,010 | $457,289 | $369,214 |
| Short-term debt | $4.4M | $2.2M | $2.2M | $89,902 | $90,982 | $123,220 | $115,431 | — | $1.2M | $2.5M |
| Deferred revenue | $503,000 | $473,000 | $171,841 | $164,309 | $1.4M | $285,795 | $580,014 | $610,625 | $507,160 | $386,581 |
| Total current liabilities | $21.3M | $18.7M | $17.9M | $8.4M | $9.4M | $10.0M | $6.1M | $4.2M | $3.5M | $3.7M |
| Long-term debt | $21.4M | $30.8M | $34.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $427,000 | $377,000 | $593,063 | $234,434 | $327,708 | $448,753 | $564,184 | — | — | — |
| Other long-term liabilities | $5.9M | $4.7M | $4.7M | $144,532 | $236,726 | $325,533 | $5.7M | $2.4M | $2.6M | $2.9M |
| Total liabilities | $48.6M | $54.2M | $56.8M | $8.5M | $9.6M | $10.4M | $11.8M | $6.6M | $3.5M | $3.7M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $20,000 | $20,000 | $19,899 | $18,289 | $17,861 | $15,223 | $14,601 | $12,039 | $29,318 | $29,719 |
| Retained earnings (deficit) | −$79.2M | −$84.4M | −$64.3M | −$46.7M | −$35.3M | −$35.6M | −$33.4M | −$30.3M | −$30.4M | −$28.3M |
| Treasury stock | — | — | — | −$1,214 | — | — | — | — | — | — |
| Accumulated other comprehensive income | — | — | $0 | $0 | — | — | $0 | −$104,702 | −$74,276 | −$25,689 |
| Total shareholders' equity | $128.3M | $117.0M | $126.6M | $126.1M | $131.4M | $50.0M | $44.9M | $18.5M | $6.2M | $7.8M |
| Key figures | ||||||||||
| Total debt | $26.1M | $33.2M | $36.8M | $234,434 | $327,708 | $448,753 | $564,184 | — | $1.2M | $2.5M |
| Net cash (debt) | −$2.7M | −$19.8M | −$23.0M | $73.9M | $84.4M | $10.1M | $18.3M | — | $3.9M | $4.5M |
| Working capital | $43.5M | $35.3M | $36.4M | $90.2M | $105.7M | $22.8M | $21.0M | $11.7M | $5.3M | $6.5M |
| Tangible book value | $16.6M | $613,000 | −$1.2M | $90.4M | $106.0M | $23.1M | $16.2M | $9.5M | $4.7M | $5.6M |
| Book value per share | $6.75 | $6.40 | $7.39 | $7.09 | $7.43 | $3.37 | $3.35 | $1.56 | $0.63 | $0.79 |
| Shares outstanding | 19.0M | 18.3M | 17.1M | 17.8M | 17.7M | 14.8M | 13.4M | 11.9M | 9.8M | 9.9M |
| Current ratio | 3.04 | 2.89 | 3.04 | 11.74 | 12.29 | 3.28 | 4.44 | 3.77 | 2.49 | 2.78 |
| Quick ratio | 2.91 | 2.77 | 2.86 | 11.47 | 11.69 | 2.83 | 4.30 | 3.63 | 2.41 | 2.75 |
| Debt / equity | 0.20 | 0.28 | 0.29 | 0.00 | 0.00 | 0.01 | 0.01 | — | 0.19 | 0.32 |
| Equity / assets | 72.5% | 68.4% | 69.0% | 93.7% | 93.2% | 82.8% | 79.2% | 73.7% | 63.7% | 68.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $24.1M | $20.2M | $23.4M | $19.5M | $16.6M | $16.6M | $13.4M | $16.1M | $15.0M | $15.2M | $13.9M | $63.5M |
| Cash & equivalents | $24.1M | $20.2M | $23.4M | $19.5M | $16.6M | $16.6M | $13.4M | $16.1M | $15.0M | $15.2M | $13.9M | $9.9M |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | $0 | $53.6M |
| Receivables | $27.1M | $32.9M | $38.5M | $34.0M | $34.2M | $32.8M | $38.2M | $26.4M | $26.4M | $30.8M | $36.3M | $20.8M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$4.4M | $0 | $1 | $0 | $0 |
| Other current assets | $2.9M | $3.1M | $2.8M | $2.8M | $3.3M | $2.3M | $2.4M | $8.8M | $4.6M | $2.4M | $4.2M | $3.0M |
| Total current assets | $54.1M | $56.2M | $64.7M | $56.3M | $54.1M | $51.7M | $54.0M | $46.9M | $46.0M | $48.4M | $54.3M | $87.4M |
| Property, plant & equipment (net) | $574,000 | $459,000 | $510,000 | $600,000 | $662,000 | $453,000 | $516,000 | $583,000 | $643,000 | $680,000 | $722,000 | $297,946 |
| Goodwill & intangible assets | $103.3M | $110.6M | $111.7M | $113.3M | $114.4M | $115.4M | $116.4M | $117.3M | $125.8M | $126.8M | $127.8M | $35.1M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $6.3M | $18,000 | $28,000 | $95,000 | $162,000 | $229,000 | $296,000 | $362,000 | $434,000 | $501,000 | $568,000 | $1.1M |
| Total assets | $164.3M | $167.3M | $176.9M | $170.3M | $169.3M | $167.8M | $171.2M | $165.2M | $172.9M | $176.4M | $183.4M | $123.9M |
| Liabilities | ||||||||||||
| Accounts payable | $1.3M | $3.1M | $1.6M | $2.0M | $2.0M | $3.4M | $2.2M | $2.8M | $3.0M | $1.7M | $2.2M | $691,159 |
| Short-term debt | $1.5M | $2.2M | $4.4M | $3.5M | $3.5M | $3.4M | $2.2M | $2.2M | $3.5M | $3.7M | — | $27,687 |
| Deferred revenue | $709,000 | $669,000 | $503,000 | $395,000 | $484,000 | $511,000 | $473,000 | $786,000 | $1.1M | $904,000 | — | $188,394 |
| Total current liabilities | $9.7M | $10.5M | $21.3M | $18.5M | $21.1M | $18.4M | $18.7M | $14.5M | $15.0M | $16.8M | $17.9M | $7.7M |
| Long-term debt | $17.8M | $21.3M | $21.4M | $24.8M | $25.1M | $29.2M | $30.8M | $33.3M | $32.3M | $32.4M | $34.2M | $0 |
| Lease obligations | $473,000 | $373,000 | $427,000 | $507,000 | $548,000 | $310,000 | $377,000 | $437,000 | $490,000 | $547,000 | $593,000 | $148,642 |
| Other long-term liabilities | $5.8M | $5.9M | $5.9M | $4.8M | $3.8M | $4.0M | $4.7M | $3.0M | $4.6M | $4.7M | $4.7M | $120,955 |
| Total liabilities | $33.2M | $37.7M | $48.6M | $48.1M | $50.0M | $51.5M | $54.2M | $50.7M | $51.9M | $53.8M | $56.8M | $7.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $21,000 | $21,000 | $20,000 | $20,000 | $20,000 | $20,000 | $20,000 | $20,000 | $20,000 | $20,000 | — | $18,387 |
| Retained earnings (deficit) | −$80.4M | −$79.7M | −$79.2M | −$84.3M | −$85.0M | −$86.6M | −$84.4M | −$84.3M | −$75.2M | −$71.2M | −$64.3M | −$60.1M |
| Accumulated other comprehensive income | $11,000 | — | — | $0 | — | — | — | — | $0 | $0 | — | $0 |
| Total shareholders' equity | $131.1M | $129.6M | $128.3M | $122.3M | $119.3M | $116.3M | $117.0M | $114.5M | $121.0M | $122.5M | $126.6M | $116.1M |
| Key figures | ||||||||||||
| Total debt | $19.5M | $23.7M | $26.1M | $28.6M | $29.0M | $32.8M | $33.2M | $35.7M | $36.1M | $36.5M | $34.2M | $148,642 |
| Net cash (debt) | $4.6M | −$3.5M | −$2.7M | −$9.1M | −$12.4M | −$16.2M | −$19.8M | −$19.6M | −$21.1M | −$21.3M | −$20.4M | $63.4M |
| Working capital | $44.4M | $45.7M | $43.5M | $37.9M | $33.0M | $33.4M | $35.3M | $32.4M | $31.0M | $31.6M | $36.4M | $79.7M |
| Tangible book value | $27.8M | $19.0M | $16.6M | $9.0M | $4.9M | $895,000 | $613,000 | −$2.9M | −$4.8M | −$4.3M | −$1.2M | $81.0M |
| Book value per share | $6.98 | $6.91 | $6.62 | $6.43 | $6.27 | $6.29 | $6.35 | $6.25 | $6.63 | $6.74 | $6.97 | $6.98 |
| Shares outstanding | 18.8M | 18.8M | 19.4M | 19.0M | 19.0M | 18.5M | 18.4M | 18.3M | 18.3M | 18.2M | 18.2M | 16.6M |
| Current ratio | 5.58 | 5.37 | 3.04 | 3.05 | 2.57 | 2.82 | 2.89 | 3.23 | 3.07 | 2.88 | 3.04 | 11.35 |
| Quick ratio | 5.27 | 5.07 | 2.91 | 2.90 | 2.41 | 2.69 | 2.77 | 2.93 | 2.76 | 2.74 | 2.80 | 10.96 |
| Debt / equity | 0.15 | 0.18 | 0.20 | 0.23 | 0.24 | 0.28 | 0.28 | 0.31 | 0.30 | 0.30 | 0.27 | 0.00 |
| Equity / assets | 79.8% | 77.5% | 72.5% | 71.8% | 70.5% | 69.3% | 68.4% | 69.3% | 70.0% | 69.5% | 69.0% | 93.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 12, 2026); data from EODHD.
OPRX financial position
At the end of fiscal 2025 (December 31, 2025), OptimizeRx had total assets of $176.9 million (up 3.4% from a year earlier), total liabilities of $48.6 million and shareholders' equity of $128.3 million. It held $23.4 million in cash and short-term investments against $26.1 million of debt, net debt of $2.7 million. Its current ratio was 3.04. In the latest quarter (ended June 30, 2026) total assets were $164.3 million and equity $131.1 million.
Related: OPRX income statement, OPRX cash flow statement, OPRX key metrics. See the OPRX stock overview for the latest quote and news.
OPRX balance sheet FAQ
What are OptimizeRx's total assets?
OptimizeRx reported total assets of $176.9 million at the end of fiscal 2025 (December 31, 2025), compared with $171.2 million a year earlier.
How much debt does OptimizeRx have?
OptimizeRx had $26.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.20.
How much cash does OptimizeRx have?
OptimizeRx held $23.4 million in cash and short-term investments at the end of fiscal 2025; with $26.1 million of debt that is net debt of $2.7 million.
What is OptimizeRx's book value?
OptimizeRx's shareholders' equity (book value) was $128.3 million at the end of fiscal 2025, or $6.75 per share.
What is OptimizeRx's current ratio?
OptimizeRx had current assets of $64.7 million and current liabilities of $21.3 million, a current ratio of 3.04 (it can cover its short-term obligations).
How much goodwill does OptimizeRx have?
OptimizeRx carried $111.7 million of goodwill and intangible assets, 63.1% of total assets, at the end of fiscal 2025.